Ramipril (BluePoint Laboratories)
Welcome to the PulseAid listing for the Ramipril drug offered from BluePoint Laboratories. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | BluePoint Laboratories |
NON-PROPRIETARY NAME: | Ramipril |
SUBSTANCE NAME: | RAMIPRIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-01-01 |
END MARKETING DATE: | 0000-00-00 |
Ramipril HUMAN PRESCRIPTION DRUG Details:
Item Description | Ramipril from BluePoint Laboratories |
LABELER NAME: | BluePoint Laboratories |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1.25(mg/1) |
START MARKETING DATE: | 2014-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68001-140_d39d3d3b-3c2b-454c-b10b-aa2817882c5d |
PRODUCT NDC: | 68001-140 |
APPLICATION NUMBER: | ANDA078832 |
Other RAMIPRIL Pharmaceutical Manufacturers / Labelers: